2500291 (Part B)
Study with study medication for acute alcohol-related hepatitis (Part B MRD)
18-65
- Male
- Female
August - December
< 7 days
13
6500
Are you
- a healthy man or infertile woman
- between 18 and 65 years (inclusive)
- with a BMI between 18.5 and 30.0 kg/m² (inclusive)
- a smoker, non-smoker, or ex-smoker
- (smoking is not allowed during the stay in the unit)
- and does not use daily medication
What does this trial involve?
In study 2500291, SGS CPU is investigating study medication for acute alcohol-related hepatitis.
During +/- 20 weeks you will have the following appointments:
- a screening visit
- a stay of 1 time 5 days (4 overnight stays) and 5 times 4 days (3 overnight stays)
- 12 morning return visits
- an end of trial visit
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
EU Clinical Trial number: 2025-523262-25
